1. 102PHGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index. (25th November 2018) Authors: Suzuki, K; Yuki, S; Nakano, S; Kawamoto, Y; Nakatsumi, H; Hatanaka, K; Ando, T; Furukawa, K; Ishiguro, A; Ohta, T; Eto, K; Nakajima, J; Nakamura, M; Sogabe, S; Kato, K; Tateyama, M; Kato, S; Sekiguchi, M; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 103PHGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of cases of prior regorafenib. (25th November 2018) Authors: Tsuji, Y; Yuki, S; Sawada, K; Muranaka, T; Kobayashi, Y; Okuda, H; Ogawa, K; Minami, S; Honda, T; Dazai, M; Kato, T; Sasaki, T; Shindo, Y; Ota, S; Sato, A; Ueda, A; Saitoh, S; Nagai, H; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1095Prognostic impacts of soluble form of basigin in patients with chronic heart failure - from a prospective large clinical trial with 1, 147 patients. (28th August 2018) Authors: Satoh, K; Miyata, S; Miura, M; Ohtsuki, T; Nochioka, K; Sunamura, S; Nogi, M; Kurosawa, R; Kikuchi, N; Satoh, T; Aoki, T; Tatebe, S; Sugimura, K; Sakata, Y; Shimokawa, H Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 110PHGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction. (25th November 2018) Authors: Ishiguro, A; Yuki, S; Nakano, S; Kawamoto, Y; Sawada, K; Tsuji, Y; Honda, T; Miyagishima, T; Yoshida, S; Hatanaka, K; Sasaki, T; Muto, O; Ohnuma, H; Kato, S; Sato, A; Abe, M; Kato, K; Amano, T; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 115PHGCSG1301: A multicenter, double-blind, randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment. (25th November 2018) Authors: Dazai, M; Yuki, S; Sawada, K; Muranaka, T; Kawamoto, Y; Nakatsumi, H; Nakano, S; Ishiguro, A; Tateyama, M; Sato, A; Kobayashi, Y; Nakamura, M; Okuda, H; Takahashi, Y; Eto, K; Muto, S; Hatanaka, K; Amano, T; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 164PMulti-centered phase II trial of weekly 5-FU plus l-LV regimen as salvage line chemotherapy for oral fluorouracil resistant advanced gastric cancer (HGCSG1502). (24th November 2019) Authors: Sasaki, Y; Muranaka, T; Kawamoto, Y; Sawada, K; Nakatsumi, H; Harada, K; Miyagishima, T; Hatanaka, K; Dazai, M; Ueda, A; Sasaki, T; Shinada, K; Tsuji, Y; Yuki, S; Sakamoto, N; Nishimoto, N; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1683POne-year follow-up results of eribulin for soft-tissue sarcoma including rare subtypes in a real-world observational study in Japan. (1st October 2019) Authors: Takahashi, S; Megumi, Y; Sakata, Y; Ikezawa, H; Matsuoka, T; Kawai, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 195PHGCSG1601: A retrospective cohort study of the efficacy and safety of nab-paclitaxel plus gemcitabine (nab-P+GEM) for unresectable locally advanced pancreatic cancer (LAPC). (24th November 2019) Authors: Tanimoto, A; Yagisawa, M; Nakano, S; Kawamoto, Y; Yuki, S; Ishiguro, A; Takahata, T; Sato, A; Iwanaga, I; Ehira, N; Uebayashi, M; Muto, O; Sasaki, T; Hatanaka, K; Tateyama, M; Wakabayashi, T; Dazai, M; Minami, S; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 196PHGCSG1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first-line chemotherapy for unresectable pancreatic cancer. (25th November 2018) Authors: Yoshikawa, A; Kawamoto, Y; Yuki, S; Nakano, S; Sawada, K; Muranaka, T; Nakatsumi, H; Harada, K; Kobayashi, Y; Miyagishima, T; Saiki, T; Ishiguro, A; Saito, R; Ehira, N; Iwanaga, I; Hatanaka, K; Abe, N; Sakamoto, N; Sakata, Y; Komatsu, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 4376Clinical impacts of wide ORS morphologies on deterioration of left ventricular ejection fraction and fatal arrhythmias in patients with relatively preserved left ventricular ejection function. (28th August 2018) Authors: Kimura, Y; Nakano, M; Sakata, Y; Nochioka, K; Hasebe, Y; Abe, R; Chiba, T; Fukasawa, K; Oikawa, T; Kasahara, S; Miki, K; Sato, M; Shiroto, T; Miyata, S; Shimokawa, H Journal: European heart journal Issue: Volume 39(2018)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗